Short-acting insulin market to cross $9b by 2030
The global short-acting insulin market is anticipated to exceed $9 billion by 2030, largely fueled by the increasing prevalence of
Continue Reading
Latest
Tea Benefits Explained: Why Brewing Matters for Your Health |
Government Relaunches Sehat Sahulat Program in Islamabad |
Pakistan Unveils Landmark National Genomics Policy to Transform Healthcare |
HIV/AIDS Cases Surge in Pakistan as Government Bans Unsafe Syringes |
Pakistan Allocates Just 0.8% of GDP to Health in FY 2025-26 |
June 13, 2026